$CDLX Income Statement | Understand Stock

$CDLX

$1.65 -$0.15 (8.33%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Costs and expenses:
Partner Share and other third-party costs
Delivery costs
Sales and marketing expense
Research and development expense
General and administrative expense
Acquisition and integration costs
Acquisition, integration and divestiture costs (benefits)
Change in contingent consideration
Impairment of goodwill and intangible assets
Gain (Loss) on Disposition of Business
Depreciation and amortization expense

Total costs and expenses
Operating loss
Other (expense)/income:
Interest expense, net
Foreign currency gain/(loss)
Gain on debt extinguishment
Total other (expense)/income
Loss before income taxes
Income tax benefit
Net Loss
Net loss per share attributable to common stockholders, basic and diluted (in USD per share)
Weighted-average common shares outstanding, basic and diluted (in shares)
Net loss per share, basic (in dollars per share)
Net loss per share, diluted (in dollars per share)
Weighted-average common shares outstanding, basic (in shares)
Weighted-average common shares outstanding, diluted (in shares)

Comments